They also had more severe motor impairment ( p < 0.0001), contractures ( p < 0.01) and spasticity ( p < 0.05) at baseline (see Table 1 ), and their mean time since onset of stroke was greater, but this did not reach statistical significance ( p = 0.07).
← all excerpts
Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study.
1
0.0700
0.0700